Ioanna Kotortsi

Ms. Ioanna Kotortsi


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
TPTerezia Pincikova
Terezia Pincikova
HMHeta Merikallio
Heta Merikallio
IKIoanna Kotortsi
Ioanna Kotortsi
RKReza Karimi
Reza Karimi
CLChuan-Xing Li
Chuan-Xing Li
RKRiitta Kaarteenaho
Riitta Kaarteenaho
Mucins 5AC (MUC5AC) and 5B (MUC5B) are the major mucins providing the organizing framework for the airway’s mucus gel. We retrieved bronchial mucosal biopsies and bronchial wash (BW) samples through bronchoscopy from patients with chronic obstructive pulmonary disease (n = 38), healthy never-smokers (n = 40), and smokers with normal lung function (n = 40). The expression of MUC5AC and MUC5B was assessed immunohistochemically. The mucin concentrations in BW were determined using the slot-blot technique. The immunohistochemical expression of MUC5AC and MUC5B was localized to goblet cells and submucosal glands. Smokers had higher MUC5AC and lower MUC5B goblet cell expression and higher concentrations of soluble MUC5AC in BW than never-smokers. The MUC5B expression in goblet cells correlated positively with expiratory air flows, diffusing capacity, and the dyspnoea score. Chronic bronchitis, emphysema, and the progression of chronic airflow limitation during a median follow-up time of 8.4 years were associated with higher MUC5AC and lower MUC5B expression in goblet cells. Sustainers, slow progressors, and rapid progressors of airflow obstruction differed in their MUC5B expression at baseline. Emphysema and bronchial wall thickening on CT at a follow-up visit were associated with lower MUC5B expression at baseline. Our findings strengthen the hypothesis that MUC5AC and MUC5B are yet another contributing factor to smoking-associated lung disease progression.

Verified
Journal Article
Open access
PDF file
HMHeta Merikallio
Heta Merikallio
TPTerezia Pincikova
Terezia Pincikova
IKIoanna Kotortsi
Ioanna Kotortsi
RKReza Karimi
Reza Karimi
CLChuan-Xing Li
Chuan-Xing Li
MSMagnus C. Sköld
Magnus C. Sköld
Aberrant mucus secretion is a hallmark of chronic obstructive pulmonary disease (COPD). Expression of the membrane-tethered mucins 3A and 3B (MUC3A, MUC3B) in human lung is largely unknown. In this observational cross-sectional study, we recruited subjects 45–65 years old from the general population of Stockholm, Sweden, during the years 2007–2011. Bronchial mucosal biopsies, bronchial brushings, and bronchoalveolar lavage fluid (BALF) were retrieved from COPD patients (n = 38), healthy never-smokers (n = 40), and smokers with normal lung function (n = 40). Protein expression of MUC3A and MUC3B in bronchial mucosal biopsies was assessed by immunohistochemical staining. In a subgroup of subjects (n = 28), MUC3A and MUC3B mRNAs were quantified in bronchial brushings using microarray. Non-parametric tests were used to perform correlation and group comparison analyses. A value of p < 0.05 was considered statistically significant. MUC3A and MUC3B immunohistochemical expression was localized to ciliated cells. MUC3B was also expressed in basal cells. MUC3A and MUC3B immunohistochemical expression was equal in all study groups but subjects with emphysema had higher MUC3A expression, compared to those without emphysema. Smokers had higher mRNA levels of MUC3A and MUC3B than non-smokers. MUC3A and MUC3B mRNA were higher in male subjects and correlated negatively with expiratory air flows. MUC3B mRNA correlated positively with total cell concentration and macrophage percentage, and negatively with CD4/CD8 T cell ratio in BALF. We concluded that MUC3A and MUC3B in large airways may be a marker of disease or may play a role in the pathophysiology of airway obstruction.

1 September 2016
Verified
Conference Paper
Closed access
RKReza Karimi
Reza Karimi
IKIoanna Kotortsi
Ioanna Kotortsi
AWAsa M Wheelock
Asa M Wheelock
SNSven Nyren
Sven Nyren
MSMagnus C. Sköld
Magnus C. Sköld
Aim: We studied the extent of emphysema by visual CT assessment, percentage of attenuation values lower than -950 Hounsfield units (LA-950) and on chest x-ray. Materials and methods: Forty smokers with normal lung function (mean age 54), and 40 patients with COPD of GOLD stage I-II, mean age 59 (31 current smokers and 9 ex-smokers) performed inspiratory CT scans. LA-950 was recorded and the scans were blindly scoredfor emphysema by two experienced reviewers, (0 =25%). Lateral and posteroanterior chest X-ray was evaluated using four criteria: Depressed/flattening of diaphragm with blunting of costophrenic angels; irregular radiolucency of the lung fields; retrosternal space >2.5 cm and a sternodiphragmatic angel >90°. Results: LA-950 was for smokers 21 ± 6.6 (mean ± SD), COPD current smokers 26 ± 5.5 and COPD ex-smokers 34.5 ± 5.2 (p< 0.01 between all). On visual scoring 55, 22, 22 and 0 % of the smokers were judged having different extension of emphysema, while the corresponding percentage of COPD patients was 27, 2, 51 and 16. On chest X-ray, the percentage of individuals with 2 or more radiographic criteria was 20% for smokers and 56% for COPD (p 0.01). LA-950 did not correlate with visual CT scoring while a correlation was found between chest x-ray and visual CT scoring. Conclusion: Attenuation based quantification of emphysema was not sensitive for detection of mild emphysema. Criteria on chest x-ray indicating hyperinflation may be useful in selection of patients for further CT examination.